NCT06311227 2026-03-18
Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia
National Cancer Institute (NCI)
Phase 2 Recruiting
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Washington
University of Washington
Mayo Clinic
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group